Anhedonia: Why You Can't Feel Pleasure Anymore

You still go to the concert. You still open the app your friends are messaging in. You still take the bite of the meal everyone’s raving about. And nothing happens. Not sadness, not boredom exactly, just a flat, muted absence where enjoyment used to be.

That absence has a name: anhedonia. It is not laziness, and it is not a personality change. It is a measurable disruption in the circuitry your brain uses to register reward, and it shows up in depression, ADHD, PTSD, and several other conditions, often long before anyone treating you thinks to ask about it directly.

What This Page Covers

• What anhedonia is and how it differs from sadness or low motivation
• The reward circuitry behind it
• Which conditions commonly include anhedonia, including depression and ADHD
• Why standard antidepressants don’t always fix it
• Treatments with the strongest evidence for anhedonia specifically
• How SiggyMD tracks this symptom instead of letting it hide until the next visit

What Anhedonia Actually Is

Your brain evolved a reward system for a reason: to make food, connection, and effort feel worth repeating. According to a foundational review in Current Behavioral Neuroscience Reports, anhedonia reflects an underlying dysregulation in how the brain processes reward, not simply a dip in mood. The clinical definition covers two overlapping experiences: a reduced ability to feel pleasure in the moment, and a reduced drive to anticipate or pursue things that should feel rewarding in the first place.

That distinction matters clinically. Some people with anhedonia still want to do things but get nothing out of them once they start. Others lose the pull toward the activity entirely. Both patterns trace back to the same neural territory: the mesolimbic dopamine pathway connecting the ventral tegmental area, the nucleus accumbens, and the prefrontal cortex, the brain’s system for anticipating, valuing, and learning from reward with precision. When that circuitry is disrupted, the world doesn’t necessarily look different. It just stops registering as worth reaching for.

For decades, the default clinical approach treated anhedonia as a byproduct of depressed mood: fix the sadness, and the flatness would lift on its own. A 2025 narrative review in Psychiatry and Clinical Neurosciences Reports describes anhedonia as an independent transdiagnostic domain and notes that traditional antidepressants are often only partially effective against it, even when they succeed at treating mood. The results of that older approach are real for a lot of people. But anhedonia is no longer treated as a footnote to depression, and a care model that only screens for sadness will miss it.

Anhedonia Shows Up Far Beyond Depression

Anhedonia is one of two symptoms required to diagnose a major depressive episode, and it is common there. A 2019 study in Frontiers in Psychiatry reports that anhedonia affects approximately 75 percent of patients with major depressive disorder and is associated with poorer disease prognosis and a harder response to treatment. But depression is not the only place it lives.

A 2025 network analysis published in the APA journal Focus found that anhedonia severity was central to symptom clusters across major depressive disorder, anxiety sensitivity, ADHD, and autism spectrum disorder, functioning as a shared, transdiagnostic feature rather than a depression-specific one. In ADHD specifically, researchers describe a pattern of low hedonic tone, a blunted baseline response to reward that can look a lot like depressive anhedonia. A study in Neuropsychiatric Disease and Treatment found that adults with treatment-resistant depression had a 34 percent rate of previously undetected ADHD, with chronic anhedonia and prior SSRI failures as significant predictors of that undetected ADHD.

“Anhedonia is one of the symptoms patients describe the least, and it’s one of the ones I ask about the most,” says Wendy Delgado, P.A., of the SiggyMD clinical team. “People will tell me their sleep is fine and their appetite is fine, and then almost as an aside mention that nothing feels like anything anymore. That single sentence changes the whole treatment conversation, especially if ADHD has never been part of the picture.”

Anhedonia also appears in PTSD, schizophrenia, bipolar depression, and some chronic inflammatory and neurological conditions, which is part of why it is treated as a symptom to evaluate on its own rather than an automatic sign of any single diagnosis.

Why Your SSRI Might Not Be Touching It

SSRIs work primarily by increasing serotonin availability, and they remain a reasonable first-line option for depression broadly. But reward, motivation, and pleasure are governed largely by dopamine and glutamate circuits, not serotonin. A 2024 review in CNS Spectrums concluded that SSRIs may be of limited clinical utility for anhedonia and amotivation specifically, noting that escitalopram performed less effectively than agomelatine or cognitive behavioral therapy on anhedonia measures, even though SSRIs remain frontline agents for depression overall.

Some patients describe something more specific than “not helping”: a flattening of emotional range on serotonergic medication, sometimes called emotional blunting, where both bad feelings and good ones seem to dim. That is a different clinical problem than untreated depression, and it calls for a different conversation with a prescriber, not just more time on the same medication.

What Has Stronger Evidence for Anhedonia

The same 2025 treatments review found that bupropion, vortioxetine, ketamine, and agomelatine show more promising anti-anhedonic effects than traditional SSRIs and SNRIs, while behavioral activation, mindfulness-based strategies, and savoring techniques help patients re-engage with pleasurable activities directly. The review also notes that neuromodulation approaches, including repetitive transcranial magnetic stimulation, have shown effectiveness for anhedonia when targeted at reward-related brain regions.

Ketamine’s evidence is notable because of speed rather than novelty alone. A placebo-controlled crossover study in Translational Psychiatry found that a single ketamine infusion reduced anhedonia in treatment-resistant bipolar depression, and that reduction occurred independently of the reduction in general depressive symptoms. That study was small, and ketamine for anhedonia is still an active area of research rather than a settled first-line answer, but it supports the broader point: anhedonia and low mood can respond to treatment on separate timelines, through separate mechanisms.

Behavioral activation therapy, a structured approach that has patients schedule and gradually re-engage in rewarding activities rather than waiting to feel motivated first, has consistent support as a non-medication option, particularly for people whose anhedonia involves avoidance and disengagement rather than blunted in-the-moment pleasure.

About SiggyMD

Anhedonia is easy to miss in a 15-minute quarterly appointment, because it rarely announces itself the way panic or insomnia does. It just quietly subtracts the reward from everything, until someone finally asks the right question.

SiggyMD’s intake asks about it directly, and licensed prescribers review every case before anything is prescribed. If a first medication targets mood but leaves the flatness in place, that gap gets caught in your daily check-ins, not three months later at a follow-up you may or may not keep. If ADHD is part of what’s driving your reward system to run low, that gets considered too, instead of treated as a separate problem for a separate visit.

If a related symptom pattern sounds familiar, our guides on ADHD and depression and how to know if your antidepressant is working go deeper on evaluation and next steps.

Start your anonymous intake with SiggyMD and get a treatment plan that tracks whether things are actually starting to feel like something again.

What Members Are Saying

RT

R.T., 29

Anhedonia with ADHD

“I told three different providers over two years that I was ‘fine, just tired,’ because nothing felt urgent enough to bring up. It wasn’t until a check-in specifically asked whether things I used to enjoy still felt enjoyable that I actually said no, not really, and that changed my whole plan.”

JK

J.K., 38

Major Depressive Disorder

“My old antidepressant took the edge off my sadness but I still felt like I was watching my own life through glass. Switching medications based on that specific symptom, not just my overall mood score, made a bigger difference than I expected.”

Member stories reflect real experiences. Names and identifying details have been changed to protect privacy. Results vary.

Sources

1. Der-Avakian A, Markou A. Anhedonia and the brain reward circuitry in depression. Current Behavioral Neuroscience Reports. 2015.

2. Serretti A. Anhedonia: Current and future treatments. Psychiatry and Clinical Neurosciences Reports. 2025.

3. Fagiolini A, et al. Effect of venlafaxine on anhedonia and amotivation in patients with major depressive disorder. CNS Spectrums. 2024.

4. Craske MG, et al. Anhedonia as a Transdiagnostic Symptom Across Psychological Disorders: A Network Approach. Focus. 2025.

5. Sternat T, Katzman MA. Low hedonic tone and attention-deficit hyperactivity disorder: risk factors for treatment resistance in depressed adults. Neuropsychiatric Disease and Treatment. 2018.

6. Cao B, et al. The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder. Frontiers in Psychiatry. 2019.

7. Lally N, et al. Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression. Translational Psychiatry. 2014.